ConductScience.org, home

Paper19502238

LFA-1 and CD2 synergize for the Erk1/2 activation in the Natural Killer (NK) cell immunological synapse.

Zheng X and 4 others. J Biol Chem, 2009. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. LFA-1 and CD2 synergize for the Erk1/2 activation in the Natural Killer (NK) cell immunological synapse. Papers, record 19502238. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19502238

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
LFA-1 and CD2 synergize for the Erk1/2 activation in the Natural Killer (NK) cell immunological synapse.
PubMed
Journal
J Biol Chem
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
0.6
iCite
Revised in PubMed
2022-03-18
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zheng XXiaodong
2Wang YYanyan
3Wei HHaiming
4Sun RRui
5Tian ZZhigang

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Killer Cells, NaturalMajor topic
CD11a Antigen
CD2 Antigens
Flow Cytometry
HL-60 Cells
Humans
Immunological Synapses
Interleukin-2
K562 Cells
Microscopy, Confocal
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
Models, Biological
Protein Binding
Time Factors

Source PubMed

Download CSV of topics

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112209631Lipid rafts as the signaling scaffold for NK cell activation: tyrosine phosphorylation and association of LAT with phosphatidylinositol 3-kinase and phospholipase C-gamma following CD2 stimulation.Eur J Immunol2002https://conductscience.org/library/papers/12209631PubMed
26292259The biology of the human natural killer cell.J Clin Immunol1982https://conductscience.org/library/papers/6292259PubMed
311753399What is a natural killer cell?Nat Immunol2002https://conductscience.org/library/papers/11753399PubMed
48812685Measurements of Natural Killer (NK) Activity and NK-Cell QuantificationMethods1996https://conductscience.org/library/papers/8812685PubMed
515797513Cellular ligands of activating NK receptors.Trends Immunol2005https://conductscience.org/library/papers/15797513PubMed
62951597The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3.Nature1987https://conductscience.org/library/papers/2951597PubMed
78152260Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.Leukemia1994https://conductscience.org/library/papers/8152260PubMed
814513721The MAP kinases are differently utilized by CD28 and CD2 adhesion pathways in superantigen-activated Jurkat T cells.Biol Res2003https://conductscience.org/library/papers/14513721PubMed
99586352Adhesion in NK cell function.Curr Top Microbiol Immunol1998https://conductscience.org/library/papers/9586352PubMed
1015113754LFA-1 signaling through p44/42 is coupled to perforin degranulation in CD56+CD8+ natural killer cells.Blood2004https://conductscience.org/library/papers/15113754PubMed
1112445273Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses.Immunol Rev2002https://conductscience.org/library/papers/12445273PubMed
1211895890A view to a kill: signals triggering cytotoxicity.Clin Cancer Res2002https://conductscience.org/library/papers/11895890PubMed
1310380908Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily.J Leukoc Biol1999https://conductscience.org/library/papers/10380908PubMed
147508176Human natural killer cells: origin, clonality, specificity, and receptors.Adv Immunol1994https://conductscience.org/library/papers/7508176PubMed
1515145322What is the importance of the immunological synapse?Trends Immunol2004https://conductscience.org/library/papers/15145322PubMed
1611522236Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92.J Hematother Stem Cell Res2001https://conductscience.org/library/papers/11522236PubMed
1711244041The immunological synapse.Annu Rev Immunol2001https://conductscience.org/library/papers/11244041PubMed
1818287025JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18287025PubMed
1910898979Adhesion to target cells is disrupted by the killer cell inhibitory receptor.Curr Biol2000https://conductscience.org/library/papers/10898979PubMed
2015653307NK cells in innate immunity.Curr Opin Immunol2005https://conductscience.org/library/papers/15653307PubMed

See all 36 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
41554976Cholangiocarcinoma derived exosomes attenuate the anti-tumor functions of NK cells.Sci Rep2026https://conductscience.org/library/papers/41554976PubMed
40044578Boosting tumor homing of endogenous natural killer cells via therapeutic secretomes of chemically primed natural killer cells.J Immunother Cancer2025https://conductscience.org/library/papers/40044578PubMed
38054534A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy.J Extracell Vesicles2023https://conductscience.org/library/papers/38054534PubMed
35392221A Novel Sushi-IL15-PD1 CAR-NK92 Cell Line With Enhanced and PD-L1 Targeted Cytotoxicity Against Pancreatic Cancer Cells.Front Oncol2022https://conductscience.org/library/papers/35392221PubMed
29930758Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients.Oncotarget2018https://conductscience.org/library/papers/29930758PubMed
28972539CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.J Clin Invest2017https://conductscience.org/library/papers/28972539PubMed
28362335Chemical and Biological Properties of S-1-Propenyl-l-Cysteine in Aged Garlic Extract.Molecules2017https://conductscience.org/library/papers/28362335PubMed
27940100The effect of different anesthetics on tumor cytotoxicity by natural killer cells.Toxicol Lett2017https://conductscience.org/library/papers/27940100PubMed
27594784Dysregulation of Protein Kinase Gene Expression in NK Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.Gene Regul Syst Bio2016https://conductscience.org/library/papers/27594784PubMed
26716019Preventive Anti-CD2 Treatment does not Impair Parasite Control in a Murine Toxoplasmosis Model.Eur J Microbiol Immunol (Bp)2015https://conductscience.org/library/papers/26716019PubMed
26414502Improving natural killer cell cancer immunotherapy.Curr Opin Organ Transplant2015https://conductscience.org/library/papers/26414502PubMed
26013798Practical NK cell phenotyping and variability in healthy adults.Immunol Res2015https://conductscience.org/library/papers/26013798PubMed
25315772Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack.J Biol Chem2014https://conductscience.org/library/papers/25315772PubMed
21901391Role of CD44 in lymphokine-activated killer cell-mediated killing of melanoma.Cancer Immunol Immunother2012https://conductscience.org/library/papers/21901391PubMed
21792658Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface.Cancer Immunol Immunother2011https://conductscience.org/library/papers/21792658PubMed
21469116Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells.Eur J Immunol2011https://conductscience.org/library/papers/21469116PubMed
20813844Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.J Biol Chem2010https://conductscience.org/library/papers/20813844PubMed
20656012Glucocorticoid dysregulation of natural killer cell function through epigenetic modification.Brain Behav Immun2011https://conductscience.org/library/papers/20656012PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD2914PubTator's text mininghttps://conductscience.org/library/genes/914NCBI Gene
ITGAL3683PubTator's text mininghttps://conductscience.org/library/genes/3683NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MAPK35595PubTator's text mininghttps://conductscience.org/library/genes/5595NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19502238

GET https://conductscience.org/api/papers/v1/19502238/references?page=2